HUTCHMED (China) Limited (HK:0013) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
HUTCHMED (China) Limited has announced its total number of voting rights, revealing an issued share capital composed of over 871 million ordinary shares, each with one vote and none held in treasury. This information is critical for shareholders to understand their notification requirements under the Financial Conduct Authority’s rules. Additionally, the company highlights its commitment to developing targeted therapies and immunotherapies for cancer and immunological diseases, with a significant global presence and three marketed medicines.
For further insights into HK:0013 stock, check out TipRanks’ Stock Analysis page.